Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults

Documenti analoghi

• Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
  di: Meyer, J, et al.
  Pubblicazione: (2013)
• Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
  di: Meyer, J, et al.
  Pubblicazione: (2013)
• A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
  di: Rowland, R, et al.
  Pubblicazione: (2012)
• Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
  di: Harris, S, et al.
  Pubblicazione: (2013)
• Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
  di: Pathan, A, et al.
  Pubblicazione: (2012)